These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 497578)

  • 1. Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings].
    Fozard JR; Palfreyman MG; Spedding M; Wagner J; Woodward JK
    Br J Pharmacol; 1979 Nov; 67(3):461P. PubMed ID: 497578
    [No Abstract]   [Full Text] [Related]  

  • 2. Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings].
    Jung MJ; Palfreyman MG; Ribereau-Gayon G; Wagner J; Zraïka M
    Br J Pharmacol; 1979 Nov; 67(3):460P. PubMed ID: 497577
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
    Fozard JR; Spedding M; Palfreyman MG; Wagner J; Möhring J; Koch-Weser J
    J Cardiovasc Pharmacol; 1980; 2(3):229-45. PubMed ID: 6156322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function.
    Salmon GK; Ireson JD
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):60-4. PubMed ID: 5437326
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of D,L-alpha-monofluoromethyldopa to distinguish subcellular pools of aromatic amino acid decarboxylase in mouse brain.
    Gardner CR; Richards MH
    Brain Res; 1981 Jul; 216(2):291-8. PubMed ID: 6166354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the inhibition of monoamine synthesis by monofluoromethyldopa.
    Bey P; Jung MJ; Koch-Weser J; Palfreyman MG; Sjoerdsma A; Wagner J; Zraïka M
    Br J Pharmacol; 1980 Dec; 70(4):571-6. PubMed ID: 7470730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa.
    Jung MJ; Palfreyman MG; Wagner J; Bey P; Ribereau-Gayon G; Zraïka M; Koch-Weser J
    Life Sci; 1979 Mar; 24(11):1037-42. PubMed ID: 449607
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa.
    Jung MJ; Hornsperger JM; Gerhart F; Wagner J
    Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155
    [No Abstract]   [Full Text] [Related]  

  • 10. Is aromatic L-amino acid decarboxylase immunoreactivity a marker for noradrenergic sympathetic axons?
    Bell C
    J Histochem Cytochem; 1989 Jun; 37(6):919, 921. PubMed ID: 2723406
    [No Abstract]   [Full Text] [Related]  

  • 11. l-alpha-Acetylmethadol (LAAM) attenuates sympathetic function by a peripheral mechanism.
    Stickney JL; Eikenburg DC; Keedy JD
    Proc West Pharmacol Soc; 1981; 24():237-9. PubMed ID: 7255458
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of methyldopa treatment on peripheral sympathetic nerve function in the dog.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1975; 32(02):170-8. PubMed ID: 1097259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
    Maneckjee R; Baylin SB
    Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 16. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dopegit in the combined treatment of vitiligo patients].
    Mirakhmedov UM; Rakhmatov BR; Rakhmatov AB; Raimdzhanova MR; Kamzolova KP
    Vestn Dermatol Venerol; 1985 Jun; (6):56-8. PubMed ID: 4036307
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central nervous sympathetic depressant effects of alpha-methyldopa].
    Tauberger G; Kuhn P
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):33-43. PubMed ID: 4250102
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of monofluoromethyldopa (MFMD) on trace amine levels.
    Dyck LE
    Life Sci; 1987 Feb; 40(6):571-5. PubMed ID: 3807650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aminoacid decarboxylases by non-steroidal antiinflammatory drugs.
    Bruni G; Dal Pra P; Segre G
    Int J Tissue React; 1984; 6(6):463-9. PubMed ID: 6442285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.